C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2009
11/19/2009	US20090288178 Insect cell line for production of recombinant glycoproteins with sulfated complex n-glycans
11/19/2009	US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes
11/19/2009	US20090286958 Interferon-beta fusion proteins and uses
11/19/2009	US20090286733 Long-acting veterinary polypeptides and methods of producing and administering same
11/19/2009	US20090286727 DP-78-Like Nanobodies
11/19/2009	US20090286719 Modification of cupredoxin derived peptides and methods of use thereof
11/19/2009	US20090286714 Novel molecules of the card-related protein family and uses thereof
11/19/2009	US20090286283 Method and affinity column for purifying proteins
11/19/2009	US20090286282 Method for Producing Antibody Fragments
11/19/2009	US20090286281 Secretase for use in identifying modulator for treatment and prevention of alzheimers disease; Beta-site amyloid precursor protein cleaving enzyme (BACE)
11/19/2009	US20090286280 Method for achieving improved polypeptide expression
11/19/2009	US20090286279 Genetically programmed expression of selectively sulfated proteins in eubacteria
11/19/2009	US20090286265 Cripto Blocking Antibodies And Uses Thereof
11/19/2009	US20090286262 Nucleic acid, polypeptide and its use
11/19/2009	US20090286252 Nrif3, novel co-activator for nuclear hormone receptors
11/19/2009	US20090286247 Novel nucleic acid base pair
11/19/2009	US20090286224 Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
11/19/2009	US20090285933 Product and Process
11/19/2009	US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays
11/19/2009	US20090285843 Epitope sequences
11/19/2009	US20090285831 Immunointeractive molecules
11/19/2009	US20090285830 Antibodies to lymphotoxin-alpha
11/19/2009	US20090285825 Novel snake toxin
11/19/2009	US20090285824 immunoglobulins; humanizing; chimera; fragments; complementary determining regions; breast cancer
11/19/2009	US20090285821 Campylobacter Pilus Protein, Compositions and Methods
11/19/2009	US20090285818 Cripto Blocking Antibodies and Uses Thereof
11/19/2009	US20090285815 Immunoconjugates comprising cd4 and immunoglobin molecules for the treatment of hiv infection
11/19/2009	US20090285806 Methods and compositions for improving recombinant protein production
11/19/2009	US20090285805 Binding molecules
11/19/2009	US20090285803 ANTI-PirB ANTIBODIES
11/19/2009	US20090285795 Method for the Production of a Monoclonal Antibody to CD20 for the Treatment of B-Cell Lymphoma
11/19/2009	US20090285793 Thrombinase having a molecular weight of 31,000 to 32,000; used for dissolving blood clots; culturing a filtrate of Bacillus sphaericus sero type H5a 5b; filtration, salting out the retentate, decolourizing, purifying and dialyzing.
11/19/2009	CA2724391A1 Oilseed protein concentrates and isolates, and processes for the production thereof
11/19/2009	CA2724052A1 Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
11/18/2009	EP2119794A1 Prevention of incorporation of non-standard amino acids into protein
11/18/2009	EP2119793A1 Methods for producing modified glycoproteins
11/18/2009	EP2119785A1 Novel peptides
11/18/2009	EP2119780A1 Genetically recombinant antibody composition having enhanced effector activity
11/18/2009	EP2119777A1 Gaba neuron progenitor cell marker 65b13
11/18/2009	EP2118299A1 Enzyme production in culture medium comprising raw glycerol
11/18/2009	EP2117571A2 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
11/18/2009	EP1765994B1 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
11/18/2009	EP1499349B1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/18/2009	EP1453977B1 Molecular characteristics of non-small cell lung cancer
11/18/2009	EP1385968B1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/18/2009	EP0960127B1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
11/18/2009	EP0914422B1 Mammalian genes involved in viral infection
11/18/2009	EP0758904B1 Methods and compositions for the treatment of glomerulonephritis
11/18/2009	EP0662133B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
11/18/2009	CN101583624A Compositions and methods for diagnosing and treating cancer
11/18/2009	CN101581723A Kit used for detecting bovine abortus Chlamydia psittaci antibody and preparation method thereof
11/18/2009	CN101580861A Biologically active peptide capable of inhibiting after-fermentation of acidified milk and preparation method thereof
11/18/2009	CN101580846A Human cytoglobin for preventing and curing cirrhosis and preparation method thereof
11/18/2009	CN101580818A Method for inducing the differentiation of mesenchymal stem cells of human embryo livers into islet beta-like cells and stably expressing insulin and special induced liquid thereof
11/18/2009	CN101580538A WT1-origin HLA-DR-binding antigen peptide
11/18/2009	CN101579521A Abortus Chlamydia psittaci vaccine and preparation method thereof
11/18/2009	CN100560731C Process for producing nisin using plant cake dregs as raw material
11/18/2009	CN100560720C Methods of delivery of exogenous proteins to the cytosol and uses thereof
11/17/2009	US7619080 Oligonucleotides of a chicken leukemia inhibitory factor (LIF) gene
11/17/2009	US7619078 T cell costimulatory molecule genes; used to identify components of the signal transduction pathway induced in a cell
11/17/2009	US7619071 Humanized monoclonal antibody; human cytokine receptors; usefulness in both basic research and as therapeutics
11/17/2009	US7619070 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
11/17/2009	US7619068 Antiovarian, pancreatic, lung or breast cancer antigen (Ovr110) antibodies that internalize upon binding to Ovr110 on a mammalian in vivo; detecting Ovr110 overexpression
11/17/2009	US7619066 IL-1ra variants
11/17/2009	US7619065 Cystine-knot fold protein
11/17/2009	US7619060 Cytoplasmic polyhedrosis virus protein complex of a polyhedrin and a VP3 polypeptide
11/17/2009	US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine
11/17/2009	US7618943 Fusion polypeptides, and use thereof in antivascular tumor therapy
11/17/2009	US7618939 Isolated azurin or residues from Pseudomonas aeruginosa; inhibiting development of premalignant lesions; expression vectors; kits
11/17/2009	US7618818 Method for detecting leptin receptor ligands
11/17/2009	US7618816 Metal-binding therapeutic peptides
11/17/2009	US7618796 Industrially producing dipeptides easily and inexpensively without going through a complex synthesis; allowing a protein having proline iminopeptidase activity to act on an L-amino acid ester and an L-amino acid to form the dipeptide
11/17/2009	US7618795 Starch process
11/17/2009	US7618793 Screening agents for diminishing cellular toxicity associated with alpha-synuclein polypeptide of Parkinson's Disease; Huntington's Disease; inclusion bodies
11/17/2009	US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009	US7618775 Cells comprise orthogonal aminoacyl-tRNA synthetase and p-acetyl-L-phenylalanine; site-directed mutagenesis; kits
11/17/2009	US7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
11/17/2009	US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
11/17/2009	US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009	US7618628 CD16A binding proteins and use for the treatment of immune disorders
11/17/2009	US7618614 Intraventricular administration of hepatocyte growth factor (HGF)
11/17/2009	CA2400117C Novel collagen-like protein clac, a precursor thereof, and genes encoding the same
11/17/2009	CA2360530C A human nuclear protein having a ww domain and a polynucleotide encoding the protein
11/17/2009	CA2230949C Synthetic peptides that inhibit il-6 activity
11/17/2009	CA2211459C A method for making heteromultimeric polypeptides
11/17/2009	CA2157577C Growth differentiation factor-8
11/12/2009	WO2009137664A1 Antibodies specific to heterodimers of bcl-2 family and uses thereof
11/12/2009	WO2009137238A2 Irx-2 modified manufacturing process
11/12/2009	WO2009135603A1 Method of generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins
11/12/2009	WO2009099672A3 Breaking immunological tolerance with a genetically encoded unnatural amino acid
11/12/2009	WO2009086539A4 Treatment and prophylaxis of amyloidosis
11/12/2009	US20090282585 Plant myb transcription factor homologs
11/12/2009	US20090282584 Expression of biologically active polypeptides in duckweed
11/12/2009	US20090282579 Plant virus-based inducible expression system
11/12/2009	US20090281168 Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/12/2009	US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
11/12/2009	US20090281035 Soluble Heterodimeric Receptors and Uses Thereof
11/12/2009	US20090281022 Method for Producing Factor VII Glycoforms
11/12/2009	US20090280562 Materials and methods for preparing dimeric growth factors
11/12/2009	US20090280536 Expression system for proteins

1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 1125